IDEXX实验室- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 IDEXX实验室公司

IDEXX Laboratories, Inc. 开发、生产和分销产品，并主要为伴侣动物兽医、牲畜和家禽、乳制品和水检测行业提供服务。该公司还提供人类医疗即时诊断和实验室诊断。其部门包括伴侣动物组 (CAG)、水质产品 (水) 以及牲畜、家禽和乳制品 (LPD)。CAG 部门为伴侣动物兽医行业提供基于诊断和信息管理的产品和服务，包括临床诊断解决方案、外部参考实验室服务以及兽医软件和服务。其水部门提供测试解决方案，用于准确检测和量化水中的各种微生物参数。其 LPD 部门提供诊断测试、服务和相关仪器，用于管理牲畜和家禽的健康状况，以提高牛奶的质量和安全性。

IDEXX实验室简介



公司代码IDXX

公司名称IDEXX Laboratories Inc

上市日期Jun 21, 1991

CEOMr. Andrew Emerson

员工数量11000

证券类型Ordinary Share

年结日Jun 21

公司地址One Idexx Drive

城市WESTBROOK

上市交易所NASDAQ Global Select Consolidated

国家United States of America

邮编04092-2041

电话12075560300

网址https://www.idexx.com/

公司代码IDXX

上市日期Jun 21, 1991

CEOMr. Andrew Emerson

IDEXX实验室公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Michael Erickson, Ph.D.

Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine

12.58K

+18.05%

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

8.69K

+3.11%

Mr. Lawrence D. (Larry) Kingsley

Independent Chairman of the Board

8.23K

+4.39%

Mr. Michael J. Lane

Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology

7.70K

--

Ms. Sharon E. Underberg

Executive Vice President, General Counsel, Corporate Secretary

6.12K

+3.08%

Mr. Andrew Emerson

Executive Vice President, Chief Executive Officer, Treasurer

3.84K

+60.39%

Mr. Daniel M. (Dan) Junius

Independent Director

3.00K

+9.56%

Mr. Michael Schreck

Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience

1.92K

+112.86%

Mr. Bruce L. Claflin

Independent Director

1.72K

--

Dr. Stuart M. Essig, Ph.D.

Independent Director

1.09K

+31.76%

名称

名称/职务

职务

持股

持股变动

Mr. Michael Erickson, Ph.D.

Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine

12.58K

+18.05%

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

8.69K

+3.11%

Mr. Lawrence D. (Larry) Kingsley

Independent Chairman of the Board

8.23K

+4.39%

Mr. Michael J. Lane

Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology

7.70K

--

Ms. Sharon E. Underberg

Executive Vice President, General Counsel, Corporate Secretary

6.12K

+3.08%

Mr. Andrew Emerson

Executive Vice President, Chief Executive Officer, Treasurer

3.84K

+60.39%

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

业务USD

名称

营收

占比

CAG Diagnostics recurring revenue

878.00M

79.14%

IDEXX VetLab consumables

375.11M

33.81%

Reference laboratory diagnostic and consulting services

367.69M

33.14%

Rapid assay products

100.24M

9.04%

CAG Diagnostics capital - instruments

85.85M

7.74%

其他

-697.43M

-62.86%

地区USD

名称

营收

占比

United States

717.87M

64.70%

Europe & Middle East & Africa (EMEA) (Region)

233.27M

21.03%

Asia Pacific

89.30M

8.05%

Canada

46.69M

4.21%

Latin America

22.33M

2.01%

业务

地区

业务USD

名称

营收

占比

CAG Diagnostics recurring revenue

878.00M

79.14%

IDEXX VetLab consumables

375.11M

33.81%

Reference laboratory diagnostic and consulting services

367.69M

33.14%

Rapid assay products

100.24M

9.04%

CAG Diagnostics capital - instruments

85.85M

7.74%

其他

-697.43M

-62.86%

股东统计

更新时间: 8月19日周二

持股股东

股东类型

持股股东

占比

The Vanguard Group, Inc.

12.30%

BlackRock Institutional Trust Company, N.A.

6.63%

State Street Investment Management (US)

4.44%

Fundsmith LLP

3.30%

Geode Capital Management, L.L.C.

3.08%

其他

70.25%

持股股东

占比

The Vanguard Group, Inc.

12.30%

BlackRock Institutional Trust Company, N.A.

6.63%

State Street Investment Management (US)

4.44%

Fundsmith LLP

3.30%

Geode Capital Management, L.L.C.

3.08%

其他

70.25%

股东类型

持股股东

占比

Investment Advisor

54.15%

Investment Advisor/Hedge Fund

32.38%

Research Firm

3.94%

Pension Fund

2.49%

Bank and Trust

2.04%

Hedge Fund

0.90%

Individual Investor

0.69%

Sovereign Wealth Fund

0.60%

Family Office

0.54%

其他

2.27%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

2278

77.56M

96.93%

-3.76M

2025Q2

2277

79.81M

99.73%

-1.01M

2025Q1

2279

79.02M

98.21%

-512.23K

2024Q4

2242

76.14M

93.59%

-5.30M

2024Q3

2152

77.90M

94.66%

-4.67M

2024Q2

2140

80.09M

96.98%

-924.14K

2024Q1

2154

77.56M

93.40%

-2.57M

2023Q4

2187

77.94M

93.84%

-2.83M

2023Q3

2153

79.23M

95.34%

-677.16K

2023Q2

2157

77.53M

93.40%

-1.56M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

The Vanguard Group, Inc.

9.84M

12.3%

+19.20K

+0.20%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

5.30M

6.63%

-132.86K

-2.44%

Jun 30, 2025

State Street Investment Management (US)

3.55M

4.44%

-95.45K

-2.62%

Jun 30, 2025

Fundsmith LLP

2.64M

3.3%

-9.04K

-0.34%

Jun 30, 2025

Geode Capital Management, L.L.C.

2.46M

3.08%

+54.40K

+2.26%

Jun 30, 2025

Baron Capital Management, Inc.

2.03M

2.54%

-27.16K

-1.32%

Jun 30, 2025

Invesco Capital Management (QQQ Trust)

1.65M

2.06%

-5.80K

-0.35%

Aug 31, 2025

Polen Capital Management, LLC

1.20M

1.49%

+1.12M

+1519.07%

Jun 30, 2025

Principal Global Investors (Equity)

1.13M

1.41%

+1.75K

+0.16%

Jun 30, 2025

William Blair & Company, L.L.C. (Research)

1.08M

1.35%

-10.27K

-0.94%

Jun 30, 2025

持股ETF



更新时间: 10月6日周一

机构名称

占比

ProShares Pet Care ETF

9.54%

iShares U.S. Medical Devices ETF

5.48%

First Trust Water ETF

5.43%

Hennessy Sustainable ETF

3.75%

Nuveen ESG Mid-Cap Growth ETF

3.53%

Adaptive Core ETF

2.75%

Invesco Raymond James SB-1 Equity ETF

2.49%

First Trust S&P 500 Economic Moat Index ETF

2.37%

SPDR S&P Health Care Equipment ETF

2.24%

First Trust NASDAQ-100 Ex-Technology Sector Index Fund

2.19%

ProShares Pet Care ETF

占比9.54%

iShares U.S. Medical Devices ETF

占比5.48%

First Trust Water ETF

占比5.43%

Hennessy Sustainable ETF

占比3.75%

Nuveen ESG Mid-Cap Growth ETF

占比3.53%

Adaptive Core ETF

占比2.75%

Invesco Raymond James SB-1 Equity ETF

占比2.49%

First Trust S&P 500 Economic Moat Index ETF

占比2.37%

SPDR S&P Health Care Equipment ETF

占比2.24%

First Trust NASDAQ-100 Ex-Technology Sector Index Fund

占比2.19%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

IDEXX实验室

关于 IDEXX实验室 公司

IDEXX实验室简介

IDEXX实验室公司高管

收入明细

股东统计

机构持股

股东持股明细

持股ETF

分红派息

拆合股

关于 IDEXX实验室公司